Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Shingo
    Junior Member
    • Mar 2012
    • 6

    #1

    Number of variants from mouse exome looks very small

    Hello everybody,

    I’m just starting to analyze mouse exome. I got mouse exome fastq files (SRR519332) looks like Agilent SureSelect mouse all exon v1 from DRA/SRA/ERA.


    Using the exome target file (S0276129_Covered.bed, 50Mb) from Agilent SureDesign, I called SNP/InDel by GATK 1.6 and AvadisNGS 1.4.6. Both of programs yielded about 6,000 variants and matching rate was about 80%. Average read depth of coverage on the target region was about 70 by GATK’s DepthOfCoverage.

    Is the number of variants reasonable?

    When I analyzed human exome (SureSelect All human 50Mb) I got about 50,000 variants. The number of variants from mouse exome looks very small compare than human.

    Thank you.
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    Mice are generally inbred strains, so there is much less genetic variation than in a human population. Consequently you might expect less variants.

    Comment

    • Shingo
      Junior Member
      • Mar 2012
      • 6

      #3
      Thank you for the reply. I understood the reason. I'm worried I had something mistake.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 10:13 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Working...